Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward D Chan
Michael D Iseman

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|November 30, 2002
Current medical treatment for tuberculosisEdward D Chan, Michael D Iseman
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Underlying host risk factors for nontuberculous mycobacterial lung diseaseEdward D Chan, Michael D Iseman
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2013
Surgery for MDR-TB?Edward D Chan, Michael D Iseman
Current Opinion in Infectious Diseases|November 4, 2008
Multidrug-resistant and extensively drug-resistant tuberculosis: a reviewEdward D Chan, Michael D Iseman
Gender Medicine|March 2, 2010
Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung diseaseEdward D Chan, Michael D Iseman
American Journal of Respiratory and Critical Care Medicine|July 3, 2008
Significance of bronchiectasis in patients with alpha1-antitrypsin deficiencyEdward D Chan, Michael D Iseman
American Journal of Respiratory and Critical Care Medicine|October 16, 2010
Should cigarette smoke exposure be a criterion to treat latent tuberculous infection?Edward D Chan, Joseph Keane, Michael D Iseman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TBEdward D Chan, Matthew J Strand, Michael D Iseman
The New England Journal of Medicine|August 9, 2008
Treatment outcomes in extensively resistant tuberculosisEdward D Chan, Matthew J Strand, Michael D Iseman
The American Journal of the Medical Sciences|March 8, 2011
Mycobacterial infections in the era of modern biologic agentsMichael D Iseman
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|November 30, 2002
Current medical treatment for tuberculosisEdward D Chan, Michael D Iseman
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Underlying host risk factors for nontuberculous mycobacterial lung diseaseEdward D Chan, Michael D Iseman
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2013
Surgery for MDR-TB?Edward D Chan, Michael D Iseman
Current Opinion in Infectious Diseases|November 4, 2008
Multidrug-resistant and extensively drug-resistant tuberculosis: a reviewEdward D Chan, Michael D Iseman
Gender Medicine|March 2, 2010
Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung diseaseEdward D Chan, Michael D Iseman
American Journal of Respiratory and Critical Care Medicine|July 3, 2008
Significance of bronchiectasis in patients with alpha1-antitrypsin deficiencyEdward D Chan, Michael D Iseman
American Journal of Respiratory and Critical Care Medicine|October 16, 2010
Should cigarette smoke exposure be a criterion to treat latent tuberculous infection?Edward D Chan, Joseph Keane, Michael D Iseman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TBEdward D Chan, Matthew J Strand, Michael D Iseman
The New England Journal of Medicine|August 9, 2008
Treatment outcomes in extensively resistant tuberculosisEdward D Chan, Matthew J Strand, Michael D Iseman
The American Journal of the Medical Sciences|March 8, 2011
Mycobacterial infections in the era of modern biologic agentsMichael D Iseman
Pageof 22